Strides Shasun receives USFDA approval for cetrizine hydrochloride

Strides Shasun has received final USFDA approval for cetirizine hydrochloride capsules, used to relieve allergy symptoms. The drug cetirizine hydrochloride will be made available in capsules, 10mg (liquid filled capsules OTC). The company will produce the drug at its facility in Bengaluru and is ready for launch. According to industry estimates , the US market for cetirizine hydrochloride capsules is approximately $ 60 million, with only one other generic player.

Company Profile : Shasun Pharmaceuticals Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*